ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

Clinical Trials Approved By NCI Last Month Are Listed

January 25, 2002

Congress Approves FY 2010 Budget. Loehrer Named Interim Director At Indiana

April 10, 2009